Pelthos Therapeutics (PTHS) Research & Development (2023 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Research & Development of $374000.0 for Q4 2025, up 31.23% year-over-year from $285000.0 in Q4 2024, and up 157.93% quarter-over-quarter from $145000.0 in Q3 2025.
Pelthos Therapeutics (PTHS) Research & Development (2023 - 2026) Analysis & Trends
Pelthos Therapeutics' Research & Development history runs 3 years deep, the most recent figure standing at $374000.0 for Q4 2025.
- In Q4 2025, Research & Development rose 31.23% year-over-year to $374000.0; the TTM figure through Dec 2025 stood at $1.2 million (up 4.12% YoY), while the FY2025 annual figure was $1.2 million, up 4.16% from the prior year.
- Research & Development for Q4 2025 stood at $374000.0, up from $145000.0 in the prior quarter.
- The five-year high for Research & Development was $2.3 million in Q4 2023, with the low at $12955.0 in Q2 2024.
- The 3-year median for Research & Development is $239649.0 (2024), against an average of $415590.9.
- The sharpest annual moves came in 2024 and 2025: Research & Development sank 87.58% in 2024, then jumped 3873.86% in 2025.
- Pelthos Therapeutics' Research & Development stood at $2.3 million in 2023, then tumbled by 87.58% to $285000.0 in 2024, then soared by 31.23% to $374000.0 in 2025.
- Business Quant data shows PTHS's Research & Development at $374000.0 in Q4 2025, $145000.0 in Q3 2025, and $514814.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 413.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 210.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 97.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -588.31 Mn |
| 10 | Pelthos Therapeutics | 96.56 Mn | 72.00 Mn | 21.23 Mn | 786,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 786,000.00 |
| Dec 31, 2025 | 374,000.00 |
| Sep 30, 2025 | 145,000.00 |
| Jun 30, 2025 | 514,814.00 |
| Mar 31, 2025 | 194,298.00 |
| Dec 31, 2024 | 285,000.00 |
| Sep 30, 2024 | 415,000.00 |
| Jun 30, 2024 | 12,955.00 |
| Mar 31, 2024 | 466,606.00 |
| Dec 31, 2023 | 2.29 Mn |
| Sep 30, 2023 | 49,132.00 |
| Jun 30, 2023 | 49,955.00 |
| Mar 31, 2023 | 186,117.00 |